Details of the Drug

General Information of Drug (ID: DMCU5LD)

Drug Name

Lonidamine

Synonyms

DICA; Doridamina; Lonidamin; Lonidamina; Lonidaminum; Dichlondazolic acid; Diclondazolic acid; AF 1890; L 4900; AF-1890; Doridamina (TN); KN-228; Lonidamina [INN-Spanish]; Lonidamine (INN); Lonidamine [BAN:INN]; Lonidaminum [INN-Latin]; TH-070; 1-(2,4-Dichlorbenzyl)-indazole-3-carboxylic acid; 1-(2,4-Dichlorobenzyl)-1H-indazole-3-carboxylic acid; 1-(2,4-dichlorobenzyl)indazole-3-carboxylic acid; 1-[(2,4-dichlorophenyl)methyl]-1H-indazole-3-carboxylic acid; 1-[(2,4-dichlorophenyl)methyl]indazole-3-carboxylic acid; 1H-Indazole-3-carboxylic acid, 1-((2,4-dichlorophenyl)methyl)-(9CI)

Indication

Disease Entry	ICD 11	Status	REF
Benign prostatic hyperplasia	GA90	Discontinued in Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C15H10Cl2N2O2
Canonical SMILES: C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O
InChI: 1S/C15H10Cl2N2O2/c16-10-6-5-9(12(17)7-10)8-19-13-4-2-1-3-11(13)14(18-19)15(20)21/h1-7H,8H2,(H,20,21)
InChIKey: WDRYRZXSPDWGEB-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 39562
ChEBI ID: CHEBI:50138
CAS Number: 50264-69-2
TTD ID: D09SIR

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022059)